Guggenheim initiated coverage on SCYNEXIS1/22/21 7:17:12 AM ET$SCYXBiotechnology: Pharmaceutical PreparationsHealth CareGet the next $SCYX alert in real time by emailGuggenheim initiated coverage of SCYNEXIS with a rating of Buy and set a new price target of $25Get the next $SCYX alert in real time by email
